{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:31Z","timestamp":1761178411332,"version":"build-2065373602"},"reference-count":85,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.canrad.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T00:22:01Z","timestamp":1311812521000},"page":"540-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suivi apr\u00e8s la radioth\u00e9rapie des cancers de la prostate\u00a0: bases scientifiques, rapport co\u00fbt\u2013b\u00e9n\u00e9fice"],"prefix":"10.1016","volume":"15","author":[{"given":"S.","family":"Supiot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Cl\u00e9ment-Colmou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bouchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rigaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2011.05.005_bib0005","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1166-7087(10)70041-5","article-title":"Projection de l\u2019incidence et de la mortalit\u00e9 par cancer urologique en France en 2010","volume":"20","author":"R\u00e9billard","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.canrad.2008.12.004","article-title":"Radioth\u00e9rapie de conformation avec modulation d\u2019intensit\u00e9 dans le cancer de prostate\u00a0: vers un nouveau standard","volume":"13","author":"Azria","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0015","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S1278-3218(10)70020-2","article-title":"Cancer de la prostate","volume":"14","author":"Vieillot","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.canrad.2009.08.144","article-title":"Curieth\u00e9rapie de prostate par iode 125\u00a0: facteurs pronostiques de longue dur\u00e9e de toxicit\u00e9 urinaire, digestive et sexuelle","volume":"13","author":"Doyen","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.canrad.2009.08.108","article-title":"Dix ans d\u2019exp\u00e9rience de la curieth\u00e9rapie prostatique par iode-125","volume":"13","author":"Salem","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canrad.2010.02.002","article-title":"\u00c9volution clinique des patients atteints d\u2019un cancer prostatique de risque interm\u00e9diaire trait\u00e9s par implants permanents d\u2019iode-125\u00a0: l\u2019exp\u00e9rience de l\u2019H\u00f4tel-Dieu de Qu\u00e9bec","volume":"14","author":"Zebentout","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.canrad.2009.07.023","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers de prostate localis\u00e9s\u00a0: facteurs de r\u00e9cidive et de tol\u00e9rance","volume":"13","author":"Charissoux","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.canrad.2010.07.226","article-title":"Radioth\u00e9rapie et hormonoth\u00e9rapie pour le cancer de la prostate\u00a0: acquis et interrogations","volume":"14","author":"Bolla","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.canrad.2009.08.106","article-title":"R\u00e9duction du volume prostatique par hormonoth\u00e9rapie avant radioth\u00e9rapie conformationnelle pour cancer de la prostate","volume":"13","author":"Helou","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1748-717X-3-15","article-title":"High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331\u00a0patients","volume":"3","author":"Lips","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.canrad.2010.06.015","article-title":"Qualit\u00e9 de vie apr\u00e8s radioth\u00e9rapie pour un cancer localis\u00e9 de la prostate","volume":"14","author":"Joly","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2009.06.024","article-title":"No impairment of quality of life 18\u00a0months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study","volume":"77","author":"Marchand","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1464-410X.2008.08117.x","article-title":"Health-related quality of life 3years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification","volume":"103","author":"Lips","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2011.05.005_bib0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.canrad.2010.07.225","article-title":"Radioth\u00e9rapie prostatique\u00a0: pr\u00e9diction de la toxicit\u00e9 tardive \u00e0 partir des donn\u00e9es dosim\u00e9triques","volume":"14","author":"de Crevoisier","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.canrad.2010.06.005","article-title":"\u00ab\u00a0Dose-painting\u00a0\u00bb\u00a0: mythe ou r\u00e9alit\u00e9\u00a0?","volume":"14","author":"Supiot","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.canrad.2010.06.013","article-title":"Apports de la radioth\u00e9rapie avec modulation d\u2019intensit\u00e9 guid\u00e9e par l\u2019image dans les cancers prostatiques","volume":"14","author":"Latorzeff","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0085","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.canrad.2009.08.111","article-title":"Facteurs de risque de toxicit\u00e9 rectale et v\u00e9sicale apr\u00e8s irradiation conformationelle prostatique (de 70\u00a0ou 80\u00a0Gy)","volume":"13","author":"Chira","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canrad.2010.02.012","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: le rectum","volume":"14","author":"Blanchard","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0360-3016(01)01730-8","article-title":"Short-course intensity-modulated radiotherapy (70GY at 2.5GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life","volume":"51","author":"Kupelian","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2007.04.013","article-title":"Health-related quality of life in patients with locally advanced prostate cancer after 76Gy intensity-modulated radiotherapy vs 70Gy conformal radiotherapy in a prospective and longitudinal study","volume":"69","author":"Lips","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.24223","article-title":"Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management","volume":"115","author":"Phan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2011.05.005_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/pcan.2009.56","article-title":"Time course of late rectal toxicity after radiation therapy for prostate cancer","volume":"13","author":"Odrazka","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.canrad.2011.05.005_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0360-3016(03)01445-7","article-title":"Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer","volume":"58","author":"O\u2019Brien","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2005.11.004","article-title":"Treatment of radiation proctitis with hyperbaric oxygen","volume":"78","author":"Jones","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","article-title":"External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?","volume":"76","author":"Choe","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2009.05.052","article-title":"Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01\u00a0trial (ISRCTN47772397)","volume":"77","author":"Syndikus","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.canrad.2010.01.009","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: le canal anal","volume":"14","author":"Moreau-Claeys","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.canrad.2010.03.013","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: intestin gr\u00eale","volume":"14","author":"\u00c9 Martin","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0430","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70Gy versus 80Gy in localized prostate cancer: 5-year results of GETUG 06\u00a0randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0150","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ijrobp.2007.08.076","article-title":"Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity","volume":"70","author":"Karlsdottir","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0435","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ijrobp.2010.03.040","article-title":"External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS)","volume":"80","author":"Malik","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(05)65855-7","article-title":"High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer","volume":"166","author":"Zelefsky","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0440","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2006.12.064","article-title":"Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer","volume":"68","author":"Skala","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0360-3016(02)02726-8","article-title":"Urodynamic changes at 18months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma","volume":"53","author":"Choo","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0175","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2011.05.005_bib0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.canrad.2010.02.007","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: la vessie","volume":"14","author":"Pointreau","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.canrad.2010.07.223","article-title":"Dysfonctions sexuelles apr\u00e8s irradiation pour cancer de la prostate","volume":"14","author":"Droupy","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0190","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.canrad.2009.07.024","article-title":"Conservation \u00e0 long terme des capacit\u00e9s sexuelles apr\u00e8s curieth\u00e9rapie de prostate par implants permanents","volume":"13","author":"Pe\u00f1a","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0195","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0090-4295(01)00940-2","article-title":"Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer","volume":"57","author":"Fisch","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2011.05.005_bib0200","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(96)00555-X","article-title":"Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer","volume":"37","author":"Mantz","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(02)02901-2","article-title":"Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function","volume":"54","author":"Bastasch","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0210","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0360-3016(02)04164-0","article-title":"Role of IMRT in reducing penile doses in dose escalation for prostate cancer","volume":"55","author":"Sethi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0215","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.juro.2008.07.038","article-title":"Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study","volume":"180","author":"Nieder","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0220","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.22083","article-title":"Cancer incidence after localized therapy for prostate cancer","volume":"107","author":"Moon","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2011.05.005_bib0225","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2009.02.011","article-title":"The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845\u00a0patients","volume":"76","author":"Bhojani","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.canrad.2010.07.227","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 (RCMI) guid\u00e9e par l\u2019image\u00a0: impact de l\u2019augmentation du volume irradi\u00e9 \u00e0 faible dose\u00a0?","volume":"14","author":"Lisbona","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0240","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S1166-7087(10)70042-7","article-title":"Recommandations en onco-urologie 2010\u00a0: cancer de la prostate","volume":"20","author":"Salomon","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0245","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-5347(05)64674-5","article-title":"Biochemical disease-free survival in men younger than 60years with prostate cancer treated with external beam radiation","volume":"168","author":"Rosser","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0250","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.ju.0000152556.53602.64","article-title":"Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis","volume":"173","author":"Horwitz","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0255","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(05)67511-8","article-title":"Prostate specific antigen only progression of prostate cancer","volume":"163","author":"Moul","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2008.03.019","article-title":"A phase I trial of preoperative radiotherapy for prostate cancer: clinical and translational studies","volume":"88","author":"Supiot","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0265","first-page":"1035","article-title":"Consensus statement: guidelines for PSA following radiation therapy","volume":"37","author":"American Society for Therapeutic Radiology and Oncology Consensus Panel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0270","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.urology.2009.04.074","article-title":"Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer","volume":"76","author":"Sheinbein","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2011.05.005_bib0275","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0360-3016(99)00235-7","article-title":"The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer","volume":"45","author":"Vicini","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0280","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0285","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ijrobp.2005.07.006","article-title":"PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis","volume":"64","author":"Ray","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncr.22341","article-title":"Prostate-specific antigen nadir within 12months of prostate cancer radiotherapy predicts metastasis and death","volume":"109","author":"Alcantara","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2011.05.005_bib0295","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2008.12.067","article-title":"Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality","volume":"75","author":"Zelefsky","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0300","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0022-5347(01)66879-4","article-title":"Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University","volume":"154","author":"Hancock","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2011.05.005_bib0310","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/annonc\/mdp365","article-title":"Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy","volume":"21","author":"de Crevoisier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0315","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0022-5347(01)66713-2","article-title":"The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394\u00a0radical prostatectomies","volume":"154","author":"Oefelein","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0320","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/1097-0142(19951215)76:12<2530::AID-CNCR2820761219>3.0.CO;2-F","article-title":"Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level","volume":"76","author":"Leibman","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2011.05.005_bib0325","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.eururo.2005.07.006","article-title":"Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up","volume":"48","author":"Chaplin","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0330","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2006.09.027","article-title":"The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome","volume":"67","author":"Vance","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0335","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.canrad.2010.07.010","article-title":"RCMI avec guidage par l\u2019image de rattrapage et TEP \u00e0 la 18F choline de patients en situation de r\u00e9cidive biochimique apr\u00e8s traitement initial radical de cancer prostatique\u00a0: r\u00e9sultats pr\u00e9liminaires","volume":"14","author":"Dewas","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0340","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0345","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1200\/JCO.1997.15.1.230","article-title":"Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations","volume":"15","author":"Lee","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0350","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":"EAU Guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0355","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.ju.0000113794.34810.d0","article-title":"Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy","volume":"171","author":"Moul","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0360","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ijrobp.2005.09.039","article-title":"Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: a secondary analysis of RTOG protocol 86-10","volume":"64","author":"Shipley","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2011.05.005_bib0365","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/cncr.11166","article-title":"Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy","volume":"97","author":"Pinover","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2011.05.005_bib0370","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2009.07.049","article-title":"Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature","volume":"57","author":"Abrahamsson","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0375","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1464-410X.2007.06770.x","article-title":"International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446\u00a0patients","volume":"99","author":"Shaw","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2011.05.005_bib0380","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.eururo.2009.02.016","article-title":"Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3\u00a0study of the South European Uroncological Group","volume":"55","author":"Calais da Silva","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0385","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.canrad.2010.07.222","article-title":"Traitements de rattrapage apr\u00e8s radioth\u00e9rapie prostatique","volume":"14","author":"Baumert","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2011.05.005_bib0390","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ejso.2006.05.015","article-title":"Salvage radical prostatectomy for radiorecurrent prostate cancer: indications and results","volume":"32","author":"Darras","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0395","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1200\/JCO.2005.03.1468","article-title":"Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0400","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1097\/01.ju.0000091875.24816.6b","article-title":"Initial results of salvage laparoscopic radical prostatectomy after radiation failure","volume":"170","author":"Vallancien","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2008.04.091","article-title":"Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer","volume":"55","author":"Murat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0410","first-page":"CD005010","article-title":"Cryotherapy for localised prostate cancer","volume":"3","author":"Shelley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2011.05.005_bib0415","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.juro.2008.04.005","article-title":"Salvage prostate cryoablation: initial results from the cryo on-line data registry","volume":"180","author":"Pisters","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2011.05.005_bib0420","doi-asserted-by":"crossref","unstructured":"Epinal 2\u00a0: 409\u00a0patients sur-irradi\u00e9s au cours d\u2019une radioth\u00e9rapie pour un cancer de la prostate en raison de la r\u00e9alisation d\u2019images portales quotidiennes. Cancer Radiother 2009;13:644.","DOI":"10.1016\/j.canrad.2009.08.004"},{"key":"10.1016\/j.canrad.2011.05.005_bib0425","doi-asserted-by":"crossref","unstructured":"Epinal 1\u00a0: sur-irradiation au cours d\u2019une radioth\u00e9rapie pour un cancer de la prostate en raison de la mauvaise utilisation d\u2019un logiciel de planification de traitement. \u00c9tude de la cohorte Epinal 1. Cancer Radiother 2009;13:644.","DOI":"10.1016\/j.canrad.2009.08.003"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321811000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321811000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:21:01Z","timestamp":1761135661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321811000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":85,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1278321811000990"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2011.05.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi apr\u00e8s la radioth\u00e9rapie des cancers de la prostate\u00a0: bases scientifiques, rapport co\u00fbt\u2013b\u00e9n\u00e9fice","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2011.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}